APA (7th ed.) Citation

Rongyu Liu, Rongyu Liu, Xinlin He, Xinlin He, Zhengyu Li, & Zhengyu Li. (2022). Positive clinical outcomes following therapy with programmed cell death protein 1/programmed cell death ligand 1 inhibitors in neuroendocrine carcinoma of the cervix. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Rongyu Liu, Rongyu Liu, Xinlin He, Xinlin He, Zhengyu Li, and Zhengyu Li. Positive Clinical Outcomes Following Therapy with Programmed Cell Death Protein 1/programmed Cell Death Ligand 1 Inhibitors in Neuroendocrine Carcinoma of the Cervix. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Rongyu Liu, et al. Positive Clinical Outcomes Following Therapy with Programmed Cell Death Protein 1/programmed Cell Death Ligand 1 Inhibitors in Neuroendocrine Carcinoma of the Cervix. Frontiers Media S.A., 2022.